Nocardia brasiliensis endophthalmitis initially misdiagnosed as uveitis: a case report.

IF 2 Q1 OPHTHALMOLOGY
Xue Zhang, Liping Du, Xuemin Jin, Jingjing Sun, Guangqi An, Lin Li, Peizeng Yang, Fuzhen Li
{"title":"Nocardia brasiliensis endophthalmitis initially misdiagnosed as uveitis: a case report.","authors":"Xue Zhang, Liping Du, Xuemin Jin, Jingjing Sun, Guangqi An, Lin Li, Peizeng Yang, Fuzhen Li","doi":"10.1186/s12348-026-00602-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Endophthalmitis caused by Nocardia brasiliensis is extremely rare and typically affects immunocompromised individuals, frequently leading to severe vision loss due to diagnostic delays. We report a case of N. brasiliensis endophthalmitis in an older man without prior history of systemic immunosuppression but with newly identified diabetes mellitus, characterized by an indolent initial course followed by fulminant progression.</p><p><strong>Case presentation: </strong>A 67-year-old man without known systemic immunosuppression presented with a two-month history of recurrent right-eye pain and redness, followed by rapid vision loss and a hypopyon. Aqueous humor analysis and metagenomic sequencing identified N. brasiliensis. Despite intravitreal amikacin, systemic antimicrobial therapy, and subsequent pars plana vitrectomy with silicone oil tamponade, intraocular inflammation advanced, resulting in worsening corneal opacification, irreversible structural damage, and a final best-corrected visual acuity of light perception.</p><p><strong>Conclusions: </strong>N. brasiliensis endophthalmitis may progress rapidly and result in severe, irreversible ocular damage, even in patients without overt systemic immunodeficiency. Early microbiologic identification and prompt, targeted antimicrobial therapy combined with timely surgical intervention are critical, although visual outcomes may remain poor in advanced cases.</p>","PeriodicalId":16600,"journal":{"name":"Journal of Ophthalmic Inflammation and Infection","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2026-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13547206/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ophthalmic Inflammation and Infection","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s12348-026-00602-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Endophthalmitis caused by Nocardia brasiliensis is extremely rare and typically affects immunocompromised individuals, frequently leading to severe vision loss due to diagnostic delays. We report a case of N. brasiliensis endophthalmitis in an older man without prior history of systemic immunosuppression but with newly identified diabetes mellitus, characterized by an indolent initial course followed by fulminant progression.

Case presentation: A 67-year-old man without known systemic immunosuppression presented with a two-month history of recurrent right-eye pain and redness, followed by rapid vision loss and a hypopyon. Aqueous humor analysis and metagenomic sequencing identified N. brasiliensis. Despite intravitreal amikacin, systemic antimicrobial therapy, and subsequent pars plana vitrectomy with silicone oil tamponade, intraocular inflammation advanced, resulting in worsening corneal opacification, irreversible structural damage, and a final best-corrected visual acuity of light perception.

Conclusions: N. brasiliensis endophthalmitis may progress rapidly and result in severe, irreversible ocular damage, even in patients without overt systemic immunodeficiency. Early microbiologic identification and prompt, targeted antimicrobial therapy combined with timely surgical intervention are critical, although visual outcomes may remain poor in advanced cases.

巴西诺卡菌眼内炎最初误诊为葡萄膜炎1例。
背景:由巴西诺卡菌引起的眼内炎极为罕见,通常影响免疫功能低下的个体,经常由于诊断延误导致严重的视力丧失。我们报告一例巴西奈米虫眼内炎在一个老年男子没有既往的全身性免疫抑制史,但新发现的糖尿病,其特点是一个缓慢的初始过程随后暴发性进展。病例介绍:67岁男性,无系统性免疫抑制,2个月右眼复发性疼痛和发红,随后出现快速视力下降和低视。房水分析和宏基因组测序鉴定了巴西乳螨。尽管玻璃体内注射阿米卡星、全身抗菌治疗和随后的玻璃体平面肌切除和硅油填塞,眼内炎症进展,导致角膜混浊恶化,不可逆的结构损伤,最终的最佳矫正视力为光感知。结论:即使在没有明显的全身免疫缺陷的患者中,巴西奈米虫眼内炎也可能迅速发展并导致严重的、不可逆的眼损伤。早期微生物鉴定和及时的靶向抗菌药物治疗结合及时的手术干预是至关重要的,尽管在晚期病例中视力结果可能仍然很差。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.80
自引率
3.40%
发文量
39
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书